Pascal H P de Jong

1.4k total citations · 1 hit paper
80 papers, 852 citations indexed

About

Pascal H P de Jong is a scholar working on Rheumatology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Pascal H P de Jong has authored 80 papers receiving a total of 852 indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Rheumatology, 25 papers in Hematology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Pascal H P de Jong's work include Rheumatoid Arthritis Research and Therapies (65 papers), Systemic Lupus Erythematosus Research (37 papers) and Autoimmune and Inflammatory Disorders Research (25 papers). Pascal H P de Jong is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (65 papers), Systemic Lupus Erythematosus Research (37 papers) and Autoimmune and Inflammatory Disorders Research (25 papers). Pascal H P de Jong collaborates with scholars based in Netherlands, Gabon and Norway. Pascal H P de Jong's co-authors include Annette H M van der Helm–van Mil, A. Weel, Elise van Mulligen, Marloes Verstappen, Radboud J. E. M. Dolhain, Johanna M. W. Hazes, Róbert de Jonge, Johanna M. W. Hazes, Maurits C. F. J. de Rotte and Jan Lindemans and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Pascal H P de Jong

71 papers receiving 830 citations

Hit Papers

Intervention with methotrexate in patients with arthralgi... 2022 2026 2023 2024 2022 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial
    2022 96 citations Marloes Verstappen, Marc R. Kok et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal H P de Jong Netherlands 16 576 219 208 126 103 80 852
Joaquim Polido‐Pereira Portugal 15 393 0.7× 126 0.6× 222 1.1× 85 0.7× 25 0.2× 54 730
A Studnicka-Benke Austria 9 393 0.7× 77 0.4× 280 1.3× 18 0.1× 56 0.5× 15 606
Nathalie Rincheval France 18 695 1.2× 229 1.0× 94 0.5× 102 0.8× 18 0.2× 34 810
Laura Hunt United Kingdom 13 621 1.1× 172 0.8× 137 0.7× 39 0.3× 23 0.2× 42 874
Lotta Larsson Sweden 7 225 0.4× 71 0.3× 213 1.0× 86 0.7× 22 0.2× 9 597
Daisuke Hoshi Japan 15 586 1.0× 177 0.8× 112 0.5× 101 0.8× 24 0.2× 53 792
Antonio Iglesias Gamarra Colombia 17 398 0.7× 66 0.3× 144 0.7× 39 0.3× 25 0.2× 94 705
Marte Schrumpf Heiberg Norway 11 849 1.5× 370 1.7× 449 2.2× 52 0.4× 39 0.4× 23 1.0k
Jinju Nishino Japan 15 540 0.9× 129 0.6× 84 0.4× 131 1.0× 50 0.5× 46 851
Virginia Ruíz-Esquide Spain 19 548 1.0× 184 0.8× 266 1.3× 61 0.5× 9 0.1× 64 896

Countries citing papers authored by Pascal H P de Jong

Since Specialization
Citations

This map shows the geographic impact of Pascal H P de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal H P de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal H P de Jong more than expected).

Fields of papers citing papers by Pascal H P de Jong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal H P de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal H P de Jong. The network helps show where Pascal H P de Jong may publish in the future.

Co-authorship network of co-authors of Pascal H P de Jong

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal H P de Jong. A scholar is included among the top collaborators of Pascal H P de Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal H P de Jong. Pascal H P de Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
5.
Willemze, Annemiek, et al.. (2024). When does obesity exert its effect in conferring risk of developing RA: a large study in cohorts of symptomatic persons at risk. RMD Open. 10(1). e003785–e003785. 5 indexed citations
6.
Dolhain, Radboud J. E. M., et al.. (2024). The impact of an online, lifestyle intervention programme on the lives of patients with a rheumatic and musculoskeletal disease: a pilot study. Lara D. Veeken. 64(6). 3309–3318. 1 indexed citations
7.
8.
Verschueren, Patrick, Maarten Boers, Paul Emery, et al.. (2023). Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time?. Annals of the Rheumatic Diseases. 83(1). 65–71. 3 indexed citations
9.
Hijnen, DirkJan, Pascal H P de Jong, P.H.M. van der Kuy, et al.. (2023). Digital Outcome Measurement to Improve Care for Patients With Immune-Mediated Inflammatory Diseases: Protocol for the IMID Registry. JMIR Research Protocols. 12. e43230–e43230. 2 indexed citations
10.
Kortekaas, Marion C, Marloes Verstappen, Sarah Ohrndorf, et al.. (2022). An ultrasound negative for subclinical synovitis in arthralgia patients: is it helpful in identifying those not developing arthritis?. Lara D. Veeken. 61(12). 4892–4897. 8 indexed citations
11.
Kuijper, T. Martijn, et al.. (2022). Meta‐Analyses on the Effects of Disease‐Modifying Antirheumatic Drugs on the Most Relevant Patient‐Reported Outcome Domains in Rheumatoid Arthritis. Arthritis Care & Research. 75(8). 1659–1672. 3 indexed citations
12.
13.
Boonen, Annelies, et al.. (2022). Clinically suspect arthralgia patients with a low educational attainment have an increased risk of developing inflammatory arthritis. Lara D. Veeken. 62(5). 1944–1949. 1 indexed citations
14.
Jong, Pascal H P de, et al.. (2022). OP0028 EARLY ACHIEVEMENT OF MINIMAL DISEASE ACTIVITY IN PSORIATIC ARTHRITIS IS ASSOCIATED WITH LONG-TERM IMPROVEMENTS IN QUALITY OF LIFE. Annals of the Rheumatic Diseases. 81. 21–21. 1 indexed citations
15.
Mulligen, Elise van, et al.. (2021). Factors that influence biological survival in rheumatoid arthritis: results of a real-world academic cohort from the Netherlands. Clinical Rheumatology. 40(6). 2177–2183. 9 indexed citations
16.
Mulligen, Elise van, A. Weel, T. Martijn Kuijper, et al.. (2020). Two-year cost effectiveness between two gradual tapering strategies in rheumatoid arthritis: cost-utility analysis of the TARA trial. Annals of the Rheumatic Diseases. 79(12). 1550–1556. 11 indexed citations
17.
Verstappen, Marloes, Elise van Mulligen, Pascal H P de Jong, & Annette H M van der Helm–van Mil. (2020). DMARD-free remission as novel treatment target in rheumatoid arthritis: A systematic literature review of achievability and sustainability. RMD Open. 6(1). e001220–e001220. 35 indexed citations
18.
Mulligen, Elise van, A. Weel, J. M. W. Hazes, Annette H M van der Helm–van Mil, & Pascal H P de Jong. (2020). Tapering towards DMARD-free remission in established rheumatoid arthritis: 2-year results of the TARA trial. Annals of the Rheumatic Diseases. 79(9). 1174–1181. 22 indexed citations
19.
Mulligen, Elise van, Pascal H P de Jong, T. Martijn Kuijper, et al.. (2019). Gradual tapering TNF inhibitors versus conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomised controlled TARA study. Annals of the Rheumatic Diseases. 78(6). 746–753. 34 indexed citations
20.
Rotte, Maurits C. F. J. de, Saskia M. F. Pluijm, Pascal H P de Jong, et al.. (2018). Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritis. PLoS ONE. 13(12). e0208534–e0208534. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joaquim Polido‐Pereira Breakdown of academic impact, for papers by A Studnicka-Benke Breakdown of academic impact, for papers by Nathalie Rincheval Breakdown of academic impact, for papers by Laura Hunt Breakdown of academic impact, for papers by Lotta Larsson Breakdown of academic impact, for papers by Daisuke Hoshi Breakdown of academic impact, for papers by Antonio Iglesias Gamarra Breakdown of academic impact, for papers by Marte Schrumpf Heiberg Breakdown of academic impact, for papers by Jinju Nishino Breakdown of academic impact, for papers by Virginia Ruíz-Esquide
Rankless by CCL
2026